H. R IN THE HOUSE OF REPRESENTATIVES A BILL

Transcription

1 I TH CONGRESS ST SESSION H. R. To amend the Public Health Service Act to require group and individual health insurance coverage and group health plans to provide for coverage of oral anticancer drugs on terms no less favorable than the coverage provided for anticancer medications administered by a health care provider. IN THE HOUSE OF REPRESENTATIVES JUNE, 0 Mr. LANCE (for himself, Mr. HIGGINS, Mr. FITZPATRICK, Mr. SMITH of New Jersey, Ms. CLARK of Massachusetts, Ms. SCHAKOWSKY, Mr. YARMUTH, Mr. HASTINGS, Mr. ISRAEL, Mr. DENT, Mr. KING of New York, and Mr. SENSENBRENNER) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Public Health Service Act to require group and individual health insurance coverage and group health plans to provide for coverage of oral anticancer drugs on terms no less favorable than the coverage provided for anticancer medications administered by a health care provider. Be it enacted by the Senate and House of Representa- tives of the United States of America in Congress assembled, smartinez on DSKTPTVNPROD with BILLS VerDate Sep 0 0: Jun, 0 Jkt 000 PO Frm 0000 Fmt Sfmt 0 E:\BILLS\H.IH H

2 smartinez on DSKTPTVNPROD with BILLS 0 SECTION. SHORT TITLE. HR IH VerDate Sep 0 0: Jun, 0 Jkt 000 PO Frm 0000 Fmt Sfmt 0 E:\BILLS\H.IH H This Act may be cited as the Cancer Drug Coverage Parity Act of 0. SEC.. PARITY IN COVERAGE FOR ORAL ANTICANCER DRUGS. (a) REQUIREMENT. () IN GENERAL. Section A of the Public Health Service Act ( U.S.C. 00gg a) is amended by adding at the end the following new subsection: (e) PARITY IN COVERAGE FOR ORAL ANTICANCER DRUGS. () IN GENERAL. Subject to paragraph (), a group health plan, and a health insurance issuer offering group or individual health insurance coverage, that provides benefits with respect to anticancer medications administered by a health care provider shall provide for coverage for prescribed, patient-administered anticancer medications that are used to kill, slow, or prevent the growth of cancerous cells and that have been approved by the Food and Drug Administration that is (A) no less favorable than the coverage for anticancer medications that is intravenously administered or injected by a health care provider; and

3 0 (B) not subject to any prior authorization, step therapy, dollar or durational limit, copayment, deductible or coinsurance that does not apply to such provider-administered anticancer medications. () LIMITATION. Paragraph () shall only apply to an anticancer medication that is prescribed based on a finding by the treating physician that the medication (A) is medically necessary for the purpose of killing, slowing, or preventing the growth of cancerous cells; or (B) is clinically appropriate in terms of type, frequency, extent site, and duration. () RESTRICTION ON CERTAIN CHANGES. A group health plan or health insurance issuer may not, in order to comply with the requirement of paragraph (), make changes to benefits or replace existing benefits with new benefits under the plan or health insurance coverage designed to have the effect of (A) imposing an increase in out-of-pocket costs with respect to anticancer medications; smartinez on DSKTPTVNPROD with BILLS HR IH VerDate Sep 0 0: Jun, 0 Jkt 000 PO Frm 0000 Fmt Sfmt 0 E:\BILLS\H.IH H

4 smartinez on DSKTPTVNPROD with BILLS (B) reclassifying benefits with respect to anticancer medications in a way that would in- crease such costs; or (C) applying more restrictive limitations on prescribed orally administered anticancer medications than on intravenously administered or injected anticancer medications. () CONSTRUCTION. Nothing in this sub- section shall be construed (A) to require the use of orally adminis- tered anticancer medications as a replacement for other anticancer medications; (B) to prohibit a group health plan or health insurance issuer from requiring prior au- thorization or imposing other appropriate utili- zation controls in approving coverage for any chemotherapy; or (C) to supersede a State law that pro- vides greater protections with respect to the 0 coverage with respect to orally administered anticancer medications than is provided under this subsection.. () CONFORMING AMENDMENT. Section (c) of the Public Health Service Act ( U.S.C. HR IH VerDate Sep 0 : Jun, 0 Jkt 000 PO Frm 0000 Fmt Sfmt 0 E:\BILLS\H.IH H

5 00gg (c)) is amended by striking section 0 and inserting sections A,, and. (b) CLARIFYING AMENDMENT REGARDING APPLICA- TION TO GRANDFATHERED PLANS. Section (a)()(a) of the Patient Protection and Affordable Care Act ( U.S.C. 0(a)()(A)) is amended by adding at the end the following new clause: (v) Section A(e).. (c) EFFECTIVE DATE. The amendments made by this section shall apply with respect to group health plans for plan years beginning on or after January, 0, and with respect to health insurance coverage offered, sold, issued, renewed, in effect, or operated in the individual or group market on or after such date. Æ smartinez on DSKTPTVNPROD with BILLS HR IH VerDate Sep 0 : Jun, 0 Jkt 000 PO Frm 0000 Fmt Sfmt 0 E:\BILLS\H.IH H